WTAP is engaged in promoting AML proliferation and differentiation arrest through the mammalian target of rapamycin mTOR signaling pathway, including its downstream effector p70 ribosomal subunit 6 kinase (pS6K), which functions as an oncogenic protein (93). This evidence concerns the gene WTAP and acute myeloid leukemia.